Singleplex Immunoassay Market
Report ID: SQMIG35J2216
Report ID: SQMIG35J2216
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35J2216 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
120
|Figures:
77
Global Singleplex Immunoassay Market size was valued at USD 202.1 Million in 2024 and is poised to grow from USD 209.17 Million in 2025 to USD 275.44 Million by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).
Diagnostic tests used to measure biomarkers, including singleplex immunoassays, are the backbone of clinical decision-making for infectious disease diagnoses. Singleplex immunoassays are the preferred choice for acute care and confirmatory testing due to their high degree of analytical sensitivity and straightforward regulatory pathways. Roche and Abbott have led the charge to build out the throughput and consistency of singleplex immunoassays across all platforms. The COVID 19 pandemic has resulted in increased demand for more dependable diagnostics for single targets, such as antigen tests and troponin, and has once again solidified the need for this testing during times of patient care.
Key trend driving the global singleplex immunoassay sector is driven by technological advancements and changing clinical needs, in addition to the foundational nature of SPIA, as the development of faster and/or greater sensitivity assays, which allow clinicians to potentially detect biomarkers at much lower concentrations, expands their clinical utility. For instance, high sensitivity cardiac troponin assays permit earlier myocardial infarction diagnosis, prompting hospitals to implement single analyte workflows in emergency departments. Similarly, improvements in lateral flow chemistry broadened point of care antigen testing during outbreaks, prompting manufacturer investment and regulatory submissions. These cause-and-effect dynamics create tangible opportunities in emerging markets, decentralised testing and therapeutic drug monitoring where focused assays demonstrate economic value.
How is AI Improving Efficiency in the Singleplex Immunoassay Market?
Singleplex immunoassays evaluate one analyte at one time and depend on throughput, accuracy, and repeatability in the clinical laboratory. Increasingly, AI and advanced data analytics will be part of laboratory information systems and diagnostic applications to enhance the management of laboratory workflows and the interpretation of results. AI-enabled analytical software tools facilitate laboratory operations by automating data analysis, identifying unusual assay performance patterns, enhancing quality control procedures, and optimizing sample scheduling. These functions lead to decreased operational errors and increased testing throughput for laboratories. As diagnostic laboratories are pressed to produce tests that produce results quickly and reliably, laboratories can be expected to use AI-enabled automation tools and analytics to improve operational efficiencies throughout immunoassay testing workflows.
Market snapshot - 2026-2033
Global Market Size
USD 202.1 Million
Largest Segment
Enzyme-Linked Immunosorbent Assay
Fastest Growth
Lateral Flow Assay
Growth Rate
3.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
The singleplex immunoassay market is segmented by assay types, product type, target analyte, application and region. Based on assay types, the market is segmented into enzyme-linked immunosorbent assay, lateral flow assay, fluorescent immunoassay and chemiluminescent immunoassay. Based on product type, the market is segmented into kits, reagents and instruments. Based on target analyte, the market is segmented into proteins, hormones, antibodies and pathogens. Based on application, the market is segmented into clinical applications, research applications, healthcare applications and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on the global singleplex immunoassay market forecast, chemiluminescent immunoassay segment dominates because its high intrinsic sensitivity and low background enable reliable detection of low abundance targets, driving preference in clinical and laboratory workflows. Enhanced signal stability and compatibility with automated platforms reduce assay variability and labor burden, causing adoption by diagnostic developers. Established reagent ecosystems and instrument support further lower implementation hurdles, reinforcing its leadership through consistent performance and seamless integration into existing diagnostic pathways.
However, fluorescent immunoassay is emerging as the most rapidly expanding area due to advances in fluorophore chemistry and sensitive detectors that make singleplex assays more adaptable for miniaturized and portable readers. Growing research applications, easier multiplex transition pathways, and vendor investment in compact instruments are accelerating uptake and creating new product and application opportunities.
Kits segment leads because ready to use assay formats simplify workflow and reduce technical variability, enabling laboratories and developers to deploy singleplex tests rapidly. The use of comprehensive kit contents and validated protocols reduces the training burden associated with clinical laboratory testing and contract testing organization, thereby speeding up the time to be ready to submit a regulatory submission and creating preference among clinical laboratories and contract testing organizations. A more efficient supply and normal quality of kits will help improve throughput and reproducibility.
However, reagents are emerging as the fastest growing area as demand for specialized antibodies and detection of chemistries rises, enabling assay customization and improved sensitivity. The development of new assays and the expansion of the market will be driven by widespread innovation in reagent quality and stability. Increased capacity for contract manufacturing; and the establishment of standards for reagents. New opportunities for niche markets and specialized suppliers will also result from these factors.
To get detailed segments analysis, Request a Free Sample Report
As per the global singleplex immunoassay market analysis, North America dominates the industry due to an entrenched healthcare infrastructure, concentrated research capabilities, and a robust pipeline of diagnostic development. Laboratories and hospitals have widely adopted clinical laboratory diagnostic technology based on established reimbursement models and procurement procedures that support well-validated laboratory tests. The presence of the major diagnostics manufacturers in the industry, as well as active partnerships between the academic and commercial sectors, support timely product releases and market validation. Early adoption by the laboratory community of all laboratory technologies supported by the large distributor networks and service will maintain the market leader position.
United States Singleplex Immunoassay Market
Singleplex immunoassay market in the United States benefits from extensive laboratory networks, strong commercial infrastructure, and active research collaborations. Clinical demand for validated assays motivates manufacturers to prioritize assay performance and customer support. Established distribution channels and experienced service organizations facilitate deployment and maintenance of systems. Clear regulatory pathways and payers contribute to predictable market access. Partnerships between diagnostic companies and academic centers underpin product refinement and real world validation.
Canada Singleplex Immunoassay Market
Singleplex immunoassay market in Canada is characterized by integrated health systems, centralized procurement, and emphasis on efficient diagnostics. The collaboration of public health agencies with suppliers of diagnostic tests facilitates the adoption of test results for clinical and public health uses. Local regulatory and reimbursement policies influence the purchasing decisions of laboratories; in addition, cooperative relationships between research institutions and commercial companies promote the performance of validation studies. Through the use of service networks and service programs, users become more confident in the methods they are using, thus ensuring continuing use of the methods.
The expansion in Europe in the singleplex immunoassay market reflects a combination of advanced clinical diagnostics adoption, harmonized regulatory frameworks, and strong investment in translational research. The emphasis placed on accurate diagnoses and cost effectiveness by national health care systems has led to the integration of well validated tests into laboratory workflows. The use of cross border partnerships and European research consortia promotes rapid validation studies, and the creation of standards which help to standardize the performance of diagnostic tests. Activities by policy makers related to reimbursement for diagnostics have also aided in bringing about wider market adoption of diagnostics as a result of addressing the clinical need across the variety of health care delivery systems.
Germany Singleplex Immunoassay Market
Singleplex immunoassay market in Germany is anchored by a strong industrial base, advanced clinical laboratories, and collaboration between research institutions and diagnostics manufacturers. Assay providers are required to deliver a high level of performance due to customer demand for quality and validation; this is aided through structured procurement processes and by accredited laboratories within hospitals and networked specialty centers that utilize the providers' assays. The firms that manufacture diagnostics will be able to rely on engineering and design functionality they utilize for actual manufacturing.
United Kingdom Singleplex Immunoassay Market
Singleplex immunoassay market in the United Kingdom is distinguished by a combination of innovation and clinical adoption, driven by strong translational research and diagnostics companies. The focus of health systems on symptom assessment (outcomes) and diagnostic pathways (bulk testing during an illness) is facilitating the expedited adoption of proven assays. A supportive service ecosystem and specialist distributors will allow for rapid, wide distribution of the assay across hospitals and private labs and continue to build momentum in the marketplace.
France Singleplex Immunoassay Market
Singleplex immunoassay market in France is emerging with emphasis on integrating diagnostics into public health programs and clinical pathways. Laboratories prioritize assay reliability and compatibility with centralized networks, shaping supplier strategies. Collaborative initiatives among hospitals, research centers, and industry support pilot validation and clinical evaluation. Interest in biomarker driven diagnostics and personalized monitoring encourages adaptation of assay portfolios to local clinical needs.
The Asia Pacific region is strengthening its position in the singleplex immunoassay market through a combination of advanced laboratory expansion, targeted research and development investment, and growing local manufacturing capabilities. The regions continue to have a growing demand for diagnostic self dependence and technology transfer and are encouraging their local manufacturers to meet international quality standards. For this reason, there are several cooperative strategic partnerships being established among academic institutions, private diagnostic companies, and government programs to support validation and integration into the clinic. In addition to this there is now a larger number of clinical test facilities and, as a result, an improved service and distribution network that will help facilitate the deployment of tests on a wider scale.
Japan Singleplex Immunoassay Market
Singleplex immunoassay market in Japan is supported by advanced laboratory infrastructure, close collaboration between industry and academic research, and assay quality standards. Domestic diagnostics firms prioritize precision engineering and validation to match clinical laboratory workflows. Adoption of automated platforms and emphasis on continual improvement enable deployment across hospitals and laboratories. Clear regulatory processes and collaborative research initiatives facilitate clinical evaluation. Strong service networks and training programs sustain end user confidence.
South Korea Singleplex Immunoassay Market
The Korean singleplex immunoassay marketplace is growing rapidly due to significant government assistance for biotech innovation; increased capacity for producing diagnostic products; and the quick take-up of new lab technology. Strong distribution channels exist from the diagnostic manufacturers to hospitals and clinical labs, and close collaboration between diagnostic manufacturers and university research centres is increasing the adoption of assays in both settings. Government programs to support local biotech companies, and to modernize the regulatory framework that governs their operations, encourage local manufacturers to grow their diagnostic product offerings and to enhance their competitiveness on both the domestic and global markets.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Demand for Rapid Diagnostics
Growing Adoption in Clinical Laboratories
High Cost of Specialized Reagents
Regulatory Complexity for Assay Approval
Request Free Customization of this report to help us to meet your business objectives.
Consolidation and rapid platform innovation are reshaping the competitive landscape for global singleplex immunoassays market outlook. To increase their assay offerings and gain access to clinical channels, however, competitors will invest in alliances with others who have previously collaborated on launch of their platforms so as not to lose out on market share.
Workflow Integration and Automation
Biomarker Driven Assay Expansion
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global singleplex immunoassay market share is being propelled primarily by increasing demand for rapid diagnostics and further supported by growing adoption in clinical laboratories, which embed these assays into routine workflows and boost recurring reagent and instrument demand. However, growth is tempered by the high cost of specialized reagents that raise per-test expenses and curb adoption in budget-constrained settings. North America dominates the market due to established healthcare infrastructure, regulatory clarity, and strong diagnostic manufacturers. While chemiluminescent immunoassays lead the product landscape because of their high sensitivity, automation compatibility, and integration into lab platforms. Ongoing automation and biomarker driven assay expansion create further opportunity for targeted clinical use.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 202.1 Million |
| Market size value in 2033 | USD 275.44 Million |
| Growth Rate | 3.5% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Singleplex Immunoassay Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Singleplex Immunoassay Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Singleplex Immunoassay Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Singleplex Immunoassay Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Singleplex Immunoassay Market size was valued at USD 202.1 Million in 2024 and is poised to grow from USD 209.17 Million in 2025 to USD 275.44 Million by 2033, growing at a CAGR of 3.5% during the forecast period (2026-2033).
Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, Ortho Clinical Diagnostics, PerkinElmer, Quidel Corporation, Danaher Corporation, Agilent Technologies, Merck KGaA, GenScript Biotech Corporation, Becton, Dickinson and Company, EMD Millipore, Sysmex Corporation, Fujifilm Wako Pure Chemical Corporation, Miltenyi Biotec, Tecan Group, DiaSorin S.p.A., Abcam plc
The key driver of the Singleplex Immunoassay Market is the growing demand for accurate and cost-effective biomarker detection in clinical diagnostics and research. Increasing use of ELISA kits and immunoassay reagents for disease monitoring and drug development further fuels market growth.
A key market trend in the Singleplex Immunoassay Market is the shift toward high-sensitivity and automated immunoassay platforms. Increasing integration with digital data analysis, multiplex testing alternatives, and point-of-care diagnostic solutions is also shaping innovation and adoption in clinical and research laboratories.
North America accounted for the largest share in the Singleplex Immunoassay Market, driven by advanced healthcare infrastructure, high adoption of immunoassay technologies, strong clinical research activities, and widespread use of ELISA kits and diagnostic reagents.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
